| |
Latest 10 SEC filings (by transaction date) for CRMD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 13/24 | Todisco Joseph | Direct Ownership | Common Stock | P - Open market or private purchase | 13,561 | $3.74 |
Mar 20/24 | Mar 5/24 | Lefkowitz Steven W | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Stewart Robert A | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Kaplan Myron | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Dillione Janet | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Dunton Alan W | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Duncan Gregory Scott | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Jan 17/24 | Jan 12/24 | Masson-Hurlburt Elizabeth | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Jan 17/24 | Jan 12/24 | Masson-Hurlburt Elizabeth | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -4,603 | $3.47 |
Jan 17/24 | Jan 12/24 | Masson-Hurlburt Elizabeth | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 50,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CRMD within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 20/24 | Mar 5/24 | Lefkowitz Steven W | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Stewart Robert A | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Kaplan Myron | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Dillione Janet | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Dunton Alan W | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 20/24 | Mar 5/24 | Duncan Gregory Scott | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 30,000 | |
Mar 14/24 | Mar 13/24 | Todisco Joseph | Direct Ownership | Common Stock | P - Open market or private purchase | 13,561 | $3.74 |
Jan 17/24 | Jan 12/24 | Masson-Hurlburt Elizabeth | Direct Ownership | Stock Option (Right to Buy Common Stock) | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Jan 17/24 | Jan 12/24 | Masson-Hurlburt Elizabeth | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -4,603 | $3.47 |
Jan 17/24 | Jan 12/24 | Masson-Hurlburt Elizabeth | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 50,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Supernus Pharmaceuticals (OQ:SUPN) |
Eagle Pharmaceuticals (OQ:EGRX) |
TherapeuticsMD (OQ:TXMD) |